12-53482641-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001193511.2(MAP3K12):c.2162G>A(p.Arg721Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,824 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001193511.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K12 | NM_001193511.2 | c.2162G>A | p.Arg721Gln | missense_variant | 11/14 | ENST00000547488.6 | NP_001180440.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP3K12 | ENST00000547488.6 | c.2162G>A | p.Arg721Gln | missense_variant | 11/14 | 2 | NM_001193511.2 | ENSP00000449038 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000442 AC: 11AN: 248748Hom.: 0 AF XY: 0.0000518 AC XY: 7AN XY: 135134
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461600Hom.: 0 Cov.: 32 AF XY: 0.0000165 AC XY: 12AN XY: 727084
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 07, 2024 | The c.2162G>A (p.R721Q) alteration is located in exon 11 (coding exon 10) of the MAP3K12 gene. This alteration results from a G to A substitution at nucleotide position 2162, causing the arginine (R) at amino acid position 721 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at